We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
-7.3%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$314M
AUM Growth
-$88.6M
Cap. Flow
-$25M
Cap. Flow %
-7.98%
Top 10 Hldgs %
50.02%
Holding
85
New
12
Increased
22
Reduced
16
Closed
24
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
2 quarters
Top 20 Avg Time Held Equity + Options
2.4 quarters
Avg Time Held Equity only
4 quarters
Top 10 Avg Time Held Equity only
2.1 quarters
Top 20 Avg Time Held Equity only
2.4 quarters

Top Buys

Rank Stock Value
1
LKFT icon
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$13.3M
2
CI icon
Cigna
CI
+$11.1M
3
MRK icon
Merck
MRK
+$9.51M
4
CAH icon
Cardinal Health
CAH
+$5.84M
5
RCOR
Renovacor, Inc.
RCOR
+$5.23M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$8.71M
2
AMGN icon
Amgen
AMGN
+$8.53M
3
AFMD icon
Affimed
AFMD
+$6.07M
4
CHRS icon
Coherus Oncology
CHRS
+$5.72M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$5.6M

Sector Composition

Rank Sector Weight
1 Healthcare 88.4%
2 Miscellaneous 7.41%
3 Consumer Staples 2.92%
4 Industrials 0.71%
5 Financials 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CI icon
1
Cigna
CI
$75.1B
$27.7M 8.82%
138,224
+51,032
+59% +$11.1M
2020 Q3
4 quarters
CRIS icon
2
Curis
CRIS
$1.47M
$22.8M 7.27%
7,285
-1,126
-13% -$3.52M
2020 Q2
5 quarters
GLD icon
3
SPDR Gold Trust
GLD
$139B
$16.8M 5.37%
102,553
+7,123
+7% +$1.19M
2020 Q1
6 quarters
SOLY
4
DELISTED
Soliton, Inc.
SOLY
$16.8M 5.35%
824,803
– –
2020 Q2
5 quarters
UHS icon
5
Universal Health Services
UHS
$10.7B
$14M 4.46%
101,051
+27,916
+38% +$4.23M
2020 Q4
3 quarters
HCA icon
6
HCA Healthcare
HCA
$101B
$13.7M 4.36%
56,409
-9,164
-14% -$2.24M
2018 Q1
14 quarters
LKFT icon
7
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
$11.8M 3.77%
+224,719
New +$13.3M
2021 Q3
0 quarters
AVAH icon
8
Aveanna Healthcare
AVAH
$2.64B
$11.2M 3.57%
1,397,272
+195,665
+16% +$1.9M
2021 Q2
1 quarter
CNC icon
9
Centene
CNC
$34B
$11.2M 3.56%
179,232
+23,616
+15% +$1.58M
2021 Q1
2 quarters
UTHR icon
10
United Therapeutics
UTHR
$23B
$10.9M 3.48%
59,146
+12,434
+27% +$2.45M
2018 Q4
11 quarters
MRK icon
11
Merck
MRK
$358B
$9.39M 2.99%
+125,000
New +$9.51M
2021 Q3
0 quarters
HLF icon
12
Herbalife
HLF
$1.48B
$9.15M 2.92%
216,012
+61,174
+40% +$3.03M
2020 Q3
4 quarters
MCK icon
13
McKesson
MCK
$114B
$8.73M 2.78%
43,797
-5,827
-12% -$1.16M
2019 Q3
8 quarters
CAH icon
14
Cardinal Health
CAH
$56.4B
$7M 2.23%
141,423
+107,605
+318% +$5.84M
2020 Q2
5 quarters
RCOR
15
DELISTED
Renovacor, Inc.
RCOR
$6.66M 2.12%
736,323
+536,323
+268% +$5.23M
2021 Q1
2 quarters
ALBO
16
DELISTED
Albireo Pharma Inc
ALBO
$6.66M 2.12%
213,493
-52,123
-20% -$1.61M
2020 Q3
4 quarters
MIRM icon
17
Mirum Pharmaceuticals
MIRM
$5.26B
$4.96M 1.58%
248,978
-205,914
-45% -$3.35M
2020 Q4
3 quarters
ITGR icon
18
Integer Holdings
ITGR
$4.31B
$4.9M 1.56%
54,891
-11,937
-18% -$1.12M
2021 Q2
1 quarter
HQY icon
19
HealthEquity
HQY
$7.48B
$4.76M 1.52%
73,458
+8,500
+13% +$590K
2021 Q2
1 quarter
VRTX icon
20
Vertex Pharmaceuticals
VRTX
$125B
$4.63M 1.47%
25,500
+1,600
+7% +$312K
2020 Q4
3 quarters
GILD icon
21
Gilead Sciences
GILD
$187B
$4.58M 1.46%
+65,500
New +$4.6M
2021 Q3
0 quarters
KURA icon
22
Kura Oncology
KURA
$864M
$4.28M 1.36%
228,318
+6,055
+3% +$114K
2020 Q2
5 quarters
XFOR icon
23
X4 Pharmaceuticals
XFOR
$246M
$4.26M 1.36%
26,820
– –
2021 Q1
2 quarters
CCRN icon
24
DELISTED
Cross Country Healthcare
CCRN
$4.24M 1.35%
199,460
-80,390
-29% -$1.51M
2020 Q3
4 quarters
VKTX icon
25
Viking Therapeutics
VKTX
$3.31B
$4.15M 1.32%
660,813
+41,033
+7% +$253K
2017 Q4
15 quarters
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sio Capital Management held 85 positions worth $314M, down 22% from $402M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Sio Capital Management withdrew a net $25M in Q3 2021, closing 24 positions and reducing 16 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $8.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 82% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Sio Capital Management opened a new position in Lakefront Biotherapeutics American Depositary Shares worth $11.8M.

  • Sio Capital Management's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 224,719 shares worth $11.8M.
  • Sio Capital Management added most to Cigna in Q3 2021, an estimated $11.1M increase.
  • Sio Capital Management's biggest Q3 2021 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $3.96M.
  • Sio Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q3 2021, selling an estimated $8.71M.
  • Sio Capital Management's ten largest holdings make up 50% of its $314M portfolio in Q3 2021.
  • Sio Capital Management opened 12 new positions and closed 24 in Q3 2021.
  • Sio Capital Management's portfolio value fell 22% quarter-over-quarter to $314M.

Based on Sio Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.